Class information for:
Level 1: PATIENT DERIVED XENOGRAFT//FP3//PDX

Basic class information

Class id #P Avg. number of
references
Database coverage
of references
15173 727 36.2 68%



Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes

The table includes all classes above and classes immediately below the current class.



Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
307 3       INTEGRIN//ALPORT SYNDROME//LAMININ 40384
2579 2             HUMANIZED MICE//ORTHOTOPIC IMPLANTATION//SCID MICE 3666
15173 1                   PATIENT DERIVED XENOGRAFT//FP3//PDX 727

Terms with highest relevance score



rank Term termType Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 PATIENT DERIVED XENOGRAFT authKW 373683 4% 29% 31
2 FP3 authKW 216001 1% 86% 6
3 PDX authKW 137439 2% 27% 12
4 PATIENT DERIVED TUMOR XENOGRAFT authKW 95450 1% 45% 5
5 TUMORGRAFTS authKW 95450 1% 45% 5
6 PATIENT DERIVED CELL authKW 84001 0% 100% 2
7 XENOGRAFT authKW 79750 8% 3% 55
8 AFFILIATED ZHUJI HOSP address 74994 1% 36% 5
9 TUMOR XENOGRAFT MODELS authKW 74663 1% 44% 4
10 ANTIANGIOGENIC EFFECT authKW 69994 1% 33% 5

Web of Science journal categories



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 Oncology 11141 63% 0% 460
2 Pathology 340 7% 0% 49
3 Medicine, Research & Experimental 165 7% 0% 49
4 Cell Biology 158 9% 0% 69
5 CYTOLOGY & HISTOLOGY 130 1% 0% 5
6 Otorhinolaryngology 52 2% 0% 16
7 Urology & Nephrology 33 3% 0% 20
8 Mathematical & Computational Biology 18 1% 0% 9
9 Pharmacology & Pharmacy 17 6% 0% 41
10 Statistics & Probability 11 2% 0% 11

Address terms



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 AFFILIATED ZHUJI HOSP 74994 1% 36% 5
2 UNITE RECH TRANSLAT 55999 0% 67% 2
3 ZHEJIANG CANC HOSP 51687 1% 31% 4
4 ADV CANC THER EUT 42001 0% 100% 1
5 ADV TECHNOL PARTNERSHIP INITIAT 42001 0% 100% 1
6 BEIJING CANC HOSP THORAC MED ONCOL 42001 0% 100% 1
7 BELFER PL CANC SCI DERMATOL 42001 0% 100% 1
8 BREAST BIOL GRPMANCHESTER CANC 42001 0% 100% 1
9 CANC CLIN TRIALS CANADA CLIN TRIALS GRP 42001 0% 100% 1
10 CANC SURG METAB GRP 42001 0% 100% 1

Journals



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 EXPERIMENTAL CELL BIOLOGY 12589 2% 3% 11
2 CLINICAL CANCER RESEARCH 2860 4% 0% 32
3 EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY 2681 2% 1% 11
4 ADVANCES IN PHARMACOLOGY AND CHEMOTHERAPY 2331 0% 6% 1
5 ANTICANCER RESEARCH 1811 4% 0% 29
6 CANCER RESEARCH 1673 6% 0% 40
7 ONCOTARGET 1626 3% 0% 22
8 CANCER CLINICAL TRIALS 1309 0% 2% 2
9 BRITISH JOURNAL OF CANCER 1103 3% 0% 22
10 ZEITSCHRIFT FUR VERSUCHSTIERKUNDE 978 0% 1% 3

Author Key Words



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
LCSH search Wikipedia search
1 PATIENT DERIVED XENOGRAFT 373683 4% 29% 31 Search PATIENT+DERIVED+XENOGRAFT Search PATIENT+DERIVED+XENOGRAFT
2 FP3 216001 1% 86% 6 Search FP3 Search FP3
3 PDX 137439 2% 27% 12 Search PDX Search PDX
4 PATIENT DERIVED TUMOR XENOGRAFT 95450 1% 45% 5 Search PATIENT+DERIVED+TUMOR+XENOGRAFT Search PATIENT+DERIVED+TUMOR+XENOGRAFT
5 TUMORGRAFTS 95450 1% 45% 5 Search TUMORGRAFTS Search TUMORGRAFTS
6 PATIENT DERIVED CELL 84001 0% 100% 2 Search PATIENT+DERIVED+CELL Search PATIENT+DERIVED+CELL
7 XENOGRAFT 79750 8% 3% 55 Search XENOGRAFT Search XENOGRAFT
8 TUMOR XENOGRAFT MODELS 74663 1% 44% 4 Search TUMOR+XENOGRAFT+MODELS Search TUMOR+XENOGRAFT+MODELS
9 ANTIANGIOGENIC EFFECT 69994 1% 33% 5 Search ANTIANGIOGENIC+EFFECT Search ANTIANGIOGENIC+EFFECT
10 LOG10 CELL KILL 55999 0% 67% 2 Search LOG10+CELL+KILL Search LOG10+CELL+KILL

Core articles

The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.



Rank Reference # ref.
in cl.
Shr. of ref. in
cl.
Citations
1 SIOLAS, D , HANNON, GJ , (2013) PATIENT-DERIVED TUMOR XENOGRAFTS: TRANSFORMING CLINICAL SAMPLES INTO MOUSE MODELS.CANCER RESEARCH. VOL. 73. ISSUE 17. P. 5315-5319 24 65% 156
2 TENTLER, JJ , TAN, AC , WEEKES, CD , JIMENO, A , LEONG, S , PITTS, TM , ARCAROLI, JJ , MESSERSMITH, WA , ECKHARDT, SG , (2012) PATIENT-DERIVED TUMOUR XENOGRAFTS AS MODELS FOR ONCOLOGY DRUG DEVELOPMENT.NATURE REVIEWS CLINICAL ONCOLOGY. VOL. 9. ISSUE 6. P. 338 -350 37 35% 252
3 IZUMCHENKO, E , MEIR, J , BEDI, A , WYSOCKI, PT , HOQUE, MO , SIDRANSKY, D , (2016) PATIENT-DERIVED XENOGRAFTS AS TOOLS IN PHARMACEUTICAL DEVELOPMENT.CLINICAL PHARMACOLOGY & THERAPEUTICS. VOL. 99. ISSUE 6. P. 612 -621 38 56% 0
4 CHO, SY , KANG, W , HAN, JY , MIN, S , KANG, J , LEE, A , KWON, JY , LEE, C , PARK, H , (2016) AN INTEGRATIVE APPROACH TO PRECISION CANCER MEDICINE USING PATIENT-DERIVED XENOGRAFTS.MOLECULES AND CELLS. VOL. 39. ISSUE 2. P. 77 -86 32 48% 3
5 CHOI, YY , LEE, JE , KIM, H , SIM, MH , KIM, KK , LEE, G , KIM, HI , AN, JY , HYUNG, WJ , KIM, CB , ET AL (2016) ESTABLISHMENT AND CHARACTERISATION OF PATIENT-DERIVED XENOGRAFTS AS PARACLINICAL MODELS FOR GASTRIC CANCER.SCIENTIFIC REPORTS. VOL. 6. ISSUE . P. - 31 56% 1
6 SIA, D , MOEINI, A , LABGAA, I , VILLANUEVA, A , (2015) THE FUTURE OF PATIENT-DERIVED TUMOR XENOGRAFTS IN CANCER TREATMENT.PHARMACOGENOMICS. VOL. 16. ISSUE 14. P. 1671 -1683 39 41% 2
7 BROWN, KM , XUE, AQ , MITTAL, A , SAMRA, JS , SMITH, R , HUGH, TJ , (2016) PATIENT-DERIVED XENOGRAFT MODELS OF COLORECTAL CANCER IN PRECLINICAL RESEARCH: A SYSTEMATIC REVIEW.ONCOTARGET. VOL. 7. ISSUE 40. P. 66212 -66225 33 47% 0
8 HIDALGO, M , AMANT, F , BIANKIN, AV , BUDINSKA, E , BYRNE, AT , CALDAS, C , CLARKE, RB , DE JONG, S , JONKERS, J , MAELANDSMO, GM , ET AL (2014) PATIENT-DERIVED XENOGRAFT MODELS: AN EMERGING PLATFORM FOR TRANSLATIONAL CANCER RESEARCH.CANCER DISCOVERY. VOL. 4. ISSUE 9. P. 998 -1013 25 36% 115
9 ALKEMA, NG , TOMAR, T , DUIKER, EW , MEERSMA, GJ , KLIP, H , VAN DER ZEE, AGJ , WISMAN, GBA , DE JONG, S , (2015) BIOBANKING OF PATIENT AND PATIENT-DERIVED XENOGRAFT OVARIAN TUMOUR TISSUE: EFFICIENT PRESERVATION WITH LOW AND HIGH FETAL CALF SERUM BASED METHODS.SCIENTIFIC REPORTS. VOL. 5. ISSUE . P. - 26 60% 0
10 JIN, KT , TENG, LS , SHEN, YP , HE, KF , XU, ZZ , LI, GL , (2010) PATIENT-DERIVED HUMAN TUMOUR TISSUE XENOGRAFTS IN IMMUNODEFICIENT MICE: A SYSTEMATIC REVIEW.CLINICAL & TRANSLATIONAL ONCOLOGY. VOL. 12. ISSUE 7. P. 473-480 25 54% 63

Classes with closest relation at Level 1



Rank Class id link
1 10289 ORTHOTOPIC IMPLANTATION//RFP//PHOTOIMMUNOTHERAPY
2 37425 UKRAINIAN ONCOL RADIOL//TEST OF POPULATION HETEROGENEITY//ZONE OF INCREASED DENSITY
3 5913 CHEMOSENSITIVITY TEST//HISTOCULTURE DRUG RESPONSE ASSAY//CHEMOSENSITIVITY
4 8416 HUMANIZED MICE//SCID MICE//SCID MOUSE
5 21112 PAULLONES//ADV BIOINFORMAT SYST MED//NCI 60
6 37262 KRN5500//SPICAMYCIN//SPICAMYCIN DERIVATIVE
7 18910 ACINAR TO DUCTAL METAPLASIA//PANIN//KRASG12D
8 26375 CAMILLO GOLGI//IMMUNOL EXPT ONCOL//ZENTRUM BIOMED AUSBILDUNG FOR UWH ZBAF
9 9229 SPHEROID//3D CELL CULTURE//TUMOR SPHEROIDS
10 3965 EVOLUT CANC//CANCER GENOME//CANCER GENOMICS

Go to start page